| In vivo protein transduction: delivery of a biologically active protein into the mouse SR Schwarze, A Ho, A Vocero-Akbani, SF Dowdy Science 285 (5433), 1569-1572, 1999 | 3360 | 1999 |
| Tumor mutational load predicts survival after immunotherapy across multiple cancer types RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ... Nature genetics 51 (2), 202-206, 2019 | 3280 | 2019 |
| OncoKB: a precision oncology knowledge base D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ... JCO precision oncology 1, 1-16, 2017 | 2122 | 2017 |
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration H Nagahara, AM Vocero-Akbani, EL Snyder, A Ho, DG Latham, NA Lissy, ... Nature medicine 4 (12), 1449-1452, 1998 | 1289 | 1998 |
| Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer AL Ho, RK Grewal, R Leboeuf, EJ Sherman, DG Pfister, D Deandreis, ... New England Journal of Medicine 368 (7), 623-632, 2013 | 888 | 2013 |
| Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ... Nature genetics 42 (8), 715-721, 2010 | 796 | 2010 |
| Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo A Ho, SR Schwarze, SJ Mermelstein, G Waksman, SF Dowdy Cancer research 61 (2), 474-477, 2001 | 587 | 2001 |
| Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review SA Laurie, AL Ho, MG Fury, E Sherman, DG Pfister The lancet oncology 12 (8), 815-824, 2011 | 424 | 2011 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 340 | 2022 |
| Immunogenic neoantigens derived from gene fusions stimulate T cell responses W Yang, KW Lee, RM Srivastava, F Kuo, C Krishna, D Chowell, ... Nature medicine 25 (5), 767-775, 2019 | 326 | 2019 |
| Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology CK Bichakjian, T Olencki, SZ Aasi, M Alam, JS Andersen, D Berg, ... Journal of the National Comprehensive Cancer Network 14 (5), 574-597, 2016 | 320 | 2016 |
| What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) A Drilon, G Li, S Dogan, M Gounder, R Shen, M Arcila, L Wang, ... Annals of Oncology 27 (5), 920-926, 2016 | 308 | 2016 |
| Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma S McBride, E Sherman, CJ Tsai, S Baxi, J Aghalar, J Eng, WI Zhi, ... Journal of Clinical Oncology 39 (1), 30-37, 2021 | 293 | 2021 |
| Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo SA Ezhevsky, A Ho, M Becker-Hapak, PK Davis, SF Dowdy Molecular and cellular biology, 2001 | 287 | 2001 |
| Biological methods for cell-cycle synchronization of mammalian cells PK Davis, A Ho, SF Dowdy Biotechniques 30 (6), 1322-1331, 2001 | 283 | 2001 |
| Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes A Ho, SF Dowdy Current opinion in genetics & development 12 (1), 47-52, 2002 | 278 | 2002 |
| Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology CK Bichakjian, T Olencki, SZ Aasi, M Alam, JS Andersen, R Blitzblau, ... Journal of the National Comprehensive Cancer Network 16 (6), 742-774, 2018 | 252 | 2018 |
| Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen species CG Havens, A Ho, N Yoshioka, SF Dowdy Molecular and cellular biology, 2006 | 224 | 2006 |
| Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial GK Schwartz, WD Tap, LX Qin, MB Livingston, SD Undevia, ... The lancet oncology 14 (4), 371-382, 2013 | 222 | 2013 |
| The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform LGT Morris, R Chandramohan, L West, A Zehir, D Chakravarty, DG Pfister, ... JAMA oncology 3 (2), 244-255, 2017 | 217 | 2017 |
James Fagin在 mskcc.org 的电子邮件经过验证
